A randomized controlled trial with bright light and melatonin for delayed sleep phase disorder: Effects on subjective and objective sleep
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Delayed sleep phase disorder (DSPD) is assumed to be common amongst adolescents, with potentially severe consequences in terms of school attendance and daytime functioning. The most common treatment approaches for DSPD are based on the administration of bright light and/or exogenous melatonin with or without adjunct behavioural instructions. Much is generally known about the chronobiological effects of light and melatonin. However, placebo-controlled treatment studies for DSPD are scarce, in particular in adolescents and young adults, and no standardized guidelines exist regarding treatment. The aim of the present study was, therefore, to investigate the short- and long-term effects on sleep of a DSPD treatment protocol involving administration of timed bright light and melatonin alongside gradual advancement of rise time in adolescents and young adults with DSPD in a randomized controlled trial and an open label follow-up study. A total of 40 adolescents and young adults (age range 16-25 years) diagnosed with DSPD were recruited to participate in the study. The participants were randomized to receive treatment for two weeks in one of four treatment conditions: dim light and placebo capsules, bright light and placebo capsules, dim light and melatonin capsules or bright light and melatonin capsules. In a follow-up study, participants were re-randomized to either receive treatment with the combination of bright light and melatonin or no treatment in an open label trial for approximately three months. Light and capsules were administered alongside gradual advancement of rise times. The main end points were sleep as assessed by sleep diaries and actigraphy recordings and circadian phase as assessed by salivary dim light melatonin onset (DLMO). During the two-week intervention, the timing of sleep and DLMO was advanced in all treatment conditions as seen by about 1 h advance of bed time, 2 h advance of rise time and 2 h advance of DLMO in all four groups. Sleep duration was reduced with approximately 1 h. At three-month follow-up, only the treatment group had maintained an advanced sleep phase. Sleep duration had returned to baseline levels in both groups. In conclusion, gradual advancement of rise time produced a phase advance during the two-week intervention, irrespective of treatment condition. Termination of treatment caused relapse into delayed sleep times, whereas long-term treatment with bright light and melatonin (three months) allowed maintenance of the advanced sleep phase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Light Suppresses Melatonin Secretion in Humans
Lewy, A. J., Wehr, T. A., Goodwin, F. K., Newsome, D. A., & Markey, S. P. (1980) · Science · doi:10.1126/science.7434030 · Cited by 1,913 · cited 3×
“Dim light lamps have been used as placebo in previous studies (Cole et al., 2002; Pallesen et al., 2005b; Rosenthal et al., 1990; Sharkey et al., 2011) since dim light traditionally has been assumed to have minimal effect on the endogenous circadian rhythm (Lewy et al., 1980).”
BackgroundMethodThe Raven's Progressive Matrices: Change and Stability over Culture and Time
Raven, J. (2000) · Cognitive Psychology · doi:10.1006/cogp.1999.0735 · Cited by 1,560 · cited 4×
“…all serious somatic disorders (i.e. rheumatoid arthritis and diabetes), medications assumed to affect sleep (i.e. sedative anti-histamines, antidepressants and hypnotics), substance abuse or night work, IQ570 (Raven’s matrices (Raven, 2000; Raven et al., 2000)), breast feeding and pregnancy.”
BackgroundMethodInfluentialDijk, D., & Czeisler, C. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03526.1995 · Cited by 1,356
Gradisar, M., Gardner, G., & Dohnt, H. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.11.008 · Cited by 1,196 · cited 7×
“It is possible that some patients with DSPD may prevent relapse through strict adherence to early sleep schedules alone, as appears to be the case in studies by Czeisler et al. (1981) and to some extent Gradisar et al. (2011a).”
BackgroundInfluentialZeitzer, J. M., Dijk, D., Kronauer, R. E., Brown, E. N., & Czeisler, C. A. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00695.x · Cited by 1,175 · cited 4×
“However, in such case a superior effect of brighter light would still be expected (Zeitzer et al., 2000), which was not found.”
BackgroundInfluentialSleep, circadian rhythms, and delayed phase in adolescence
Crowley, S. J., Acebo, C., & Carskadon, M. A. (2007) · Sleep Medicine · doi:10.1016/j.sleep.2006.12.002 · Cited by 1,127 · cited 1×
“Associated features such as anxiety, depression, smoking and alcohol abuse may add to the burden of the disorder (Crowley et al., 2007; Saxvig et al., 2012).”
BackgroundA Phase Response Curve to Single Bright Light Pulses in Human Subjects
Khalsa, S. B. S., Jewett, M. E., Cajochen, C., & Czeisler, C. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.040477 · Cited by 1,040 · cited 2×
“Light has a maximum phase advancing effect when administered shortly after CTmin whereas bright light exposure prior to CTmin produces a phase delay (Bjorvatn & Pallesen, 2009; Khalsa et al., 2003; Minors et al., 1991).”
BackgroundBright Light Induction of Strong (Type 0) Resetting of the Human Circadian Pacemaker
Czeisler, C. A., Kronauer, R. E., Allan, J. S., Duffy, J. F., Jewett, M. E., Brown, E. N., & Ronda, J. M. (1989) · Science · doi:10.1126/science.2734611 · Cited by 946
Fishman (2006) · doi:10.1097/01 · Cited by 547
Entrainment of the human circadian system by light
Duffy, J. F., & Wright, K. P. (2005) · Journal of Biological Rhythms · doi:10.1177/0748730405277983 · Cited by 515
A new scale for measuring insomnia: the Bergen Insomnia Scale.
Pallesen, S., Bjorvatn, B., Nordhus, I. H., Sivertsen, B., Hjørnevik, M., & Morin, C. M. (2008) · Perceptual and Motor Skills · doi:10.2466/pms.107.3.691-706 · Cited by 426
Self-citationBrown, F. C., Buboltz, W. C., & Soper, B. (2002) · Behavioral Medicine · doi:10.1080/08964280209596396 · Cited by 421
Effect of Melatonin on Sleep, Behavior, and Cognition in ADHD and Chronic Sleep-Onset Insomnia
VAN der HEIJDEN, K. B., SMITS, M. G., VAN SOMEREN, E. J. W., RIDDERINKHOF, K. R., & GUNNING, W. B. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246055.76167.0d · Cited by 378 · cited 2×
“…in children and adolescents with sleep onset difficulties has been extensively explored (Eckerberg et al., 2012; Smits et al., 2001, 2003; Van der Heijden et al., 2007; Weiss et al., 2006), most DSPD treatment studies have been performed in adult populations, despite the fact that the disorder…”
BackgroundAdaptation of Human Pineal Melatonin Suppression by Recent Photic History
Smith, K. A., Schoen, M. W., & Czeisler, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032100 · Cited by 256
Sharkey, K. M., Carskadon, M. A., Figueiro, M. G., Zhu, Y., & Rea, M. S. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.01.016 · Cited by 77
Cited by
Smith, M. T., McCrae, C. S., Cheung, J., Martin, J. L., Harrod, C. G., Heald, J. L., & Carden, K. A. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7228 · Cited by 517
Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders
Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.06.005 · Cited by 393
The effects of light therapy on sleep problems: A systematic review and meta-analysis
van Maanen, A., Meijer, A. M., van der Heijden, K. B., & Oort, F. J. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.08.009 · Cited by 372
Current role of melatonin in pediatric neurology: Clinical recommendations
Bruni, O., Alonso-Alconada, D., Besag, F., Biran, V., Braam, W., Cortese, S., Moavero, R., Parisi, P., Smits, M., Van der Heijden, K., et al. (2015) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2014.12.007 · Cited by 280
Altering Adolescents’ Pre-Bedtime Phone Use to Achieve Better Sleep Health
Bartel, K., Scheeren, R., & Gradisar, M. (2019) · Health Communication · doi:10.1080/10410236.2017.1422099 · Cited by 113
Metadata
- Authors
- Saxvig, I. W., Wilhelmsen-Langeland, A., Pallesen, S., Vedaa, Ø., Nordhus, I. H., & Bjorvatn, B.
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2013-10-21
- Volume
- 31
- Issue
- 1
- Pages
- 72-86
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W2050897191
- Cited by
- 108
- References
- 15
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.